DiviDrip · PRME

PRME — Prime Medicine, Inc.

PRME is Prime Medicine, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.70. Market cap: $671M. Capital Quality Rank: 11/100 — Systemic risk.

Stock snapshot

Price$3.70
Market cap$671M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)11 / 100 · Systemic risk
ROIC (TTM)-284.6%
Shareholder buyback yield-20.27%
Altman Z-score zoneDistress

About PRME

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Listed2022Employees146HQCambridge, MASectorHealthcareWebsiteprimemedicine.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PRME. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PRME's current stock price?

PRME (Prime Medicine, Inc.) is currently trading at $3.70.

Does PRME pay a dividend?

PRME (Prime Medicine, Inc.) does not currently pay a regular dividend.

What is PRME's Capital Quality Rank?

PRME has a Capital Quality Rank of 11/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PRME in DiviDrip

Add PRME to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow